Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Access to prevention of mother-to-child transmission of HIV along HIV services cascade through integrated active case management in 15 operational districts in Cambodia.

Samreth S, Keo V, Tep R, Ke A, Ouk V, Ngauv B, Mam S, Ferradini L, Ly PS, Mean CV, Delvaux T.

J Int AIDS Soc. 2019 Oct;22(10):e25388. doi: 10.1002/jia2.25388.

2.

Integrated approach for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis is highly effective and cost-effective: an economic evaluation.

Zhang L, Tao Y, Woodring J, Rattana K, Sovannarith S, Rathavy T, Cheang K, Hossain S, Ferradini L, Deng S, Sokun C, Samnang C, Nagai M, Lo YR, Ishikawa N.

Int J Epidemiol. 2019 Aug 1;48(4):1327-1339. doi: 10.1093/ije/dyz037.

PMID:
30879066
3.

Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study.

Ségéral O, Nerrienet E, Neth S, Spire B, Khol V, Ferradini L, Sarun S, Mom C, Ngin S, Charpentier C, Men P, Mora M, Mean Chhi V, Ly P, Saphonn V.

Front Public Health. 2018 Mar 19;6:63. doi: 10.3389/fpubh.2018.00063. eCollection 2018.

4.

Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014-2015.

Rouet F, Nouhin J, Zheng DP, Roche B, Black A, Prak S, Leoz M, Gaudy-Graffin C, Ferradini L, Mom C, Mam S, Gautier C, Lesage G, Ken S, Phon K, Kerleguer A, Yang C, Killam W, Fujita M, Mean C, Fontenille D, Barin F, Plantier JC, Bedford T, Ramos A, Saphonn V.

Clin Infect Dis. 2018 May 17;66(11):1733-1741. doi: 10.1093/cid/cix1071.

5.

Adherence to PI-based 2nd-line regimens in Cambodia is not simply a question of individual behaviour: the ANRS 12276 2PICAM study.

Sagaon-Teyssier L, Mmadi Mrenda B, Khol V, Ferradini L, Mam S, Ngin S, Mora M, Maradan G, Vun Mean C, Ségéral O, Nerrienet E, Saphonn V, Spire B.

Trop Med Int Health. 2017 Nov;22(11):1428-1435. doi: 10.1111/tmi.12975. Epub 2017 Oct 2.

6.

Cluster of HIV Infections Associated With Unsafe Injection Practices in a Rural Village in Cambodia.

Saphonn V, Fujita M, Samreth S, Chan S, Rouet F, Khol V, Mam S, Mom C, Tuot S, Le LV, Ly PS, Ferradini L, Mean CV.

J Acquir Immune Defic Syndr. 2017 Jul 1;75(3):e82-e86. doi: 10.1097/QAI.0000000000001295. No abstract available.

7.

HIV Prevalence and Risks Associated with HIV Infection among Transgender Individuals in Cambodia.

Weissman A, Ngak S, Srean C, Sansothy N, Mills S, Ferradini L.

PLoS One. 2016 Apr 12;11(4):e0152906. doi: 10.1371/journal.pone.0152906. eCollection 2016.

8.

Implementation and Operational Research: Integration of Family Planning Services in a Peer-Managed HIV Care Clinic Serving Most-at-Risk Populations in Phnom Penh, Cambodia.

Thyda L, Sineng S, Delvaux T, Srean C, Mary S, Vuochnea P, Chettana P, Nirada N, Sarim C, Chantha P, Thoeun Y, Ferradini L.

J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):e120-6. doi: 10.1097/QAI.0000000000000635.

PMID:
25850605
9.

Achieving universal access and moving towards elimination of new HIV infections in Cambodia.

Vun MC, Fujita M, Rathavy T, Eang MT, Sopheap S, Sovannarith S, Chhorvann C, Vanthy L, Sopheap O, Welle E, Ferradini L, Sedtha C, Bunna S, Verbruggen R.

J Int AIDS Soc. 2014 Jun 19;17:18905. doi: 10.7448/IAS.17.1.18905. eCollection 2014. Review.

10.

Increased risk of Q151M and K65R mutations in patients failing stavudine-containing first-line antiretroviral therapy in Cambodia.

Nouhin J, Madec Y, Ngo-Giang-Huong N, Ferradini L, Nerrienet E.

PLoS One. 2013 Aug 28;8(8):e73744. doi: 10.1371/journal.pone.0073744. eCollection 2013.

11.

Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.

Durier N, Ananworanich J, Apornpong T, Ubolyam S, Kerr SJ, Mahanontharit A, Ferradini L, Ruxrungtham K, Avihingsanon A.

Clin Infect Dis. 2013 Jul;57(1):147-55. doi: 10.1093/cid/cit173. Epub 2013 Mar 19.

PMID:
23511301
12.

High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia.

Ferradini L, Ouk V, Segeral O, Nouhin J, Dulioust A, Hak C, Fournier I, Lerolle N, Ngin S, Mean CV, Delfraissy JF, Nerrienet E.

J Int AIDS Soc. 2011 Mar 26;14:14. doi: 10.1186/1758-2652-14-14.

13.

Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia.

Pujades-Rodríguez M, Schramm B, Som L, Nerrienet E, Narom P, Chanchhaya N, Ferradini L, Balkan S.

Trop Med Int Health. 2011 Feb;16(2):205-13. doi: 10.1111/j.1365-3156.2010.02689.x. Epub 2010 Nov 19.

14.

Prediction of HIV type 1 subtype C tropism by genotypic algorithms built from subtype B viruses.

Raymond S, Delobel P, Mavigner M, Ferradini L, Cazabat M, Souyris C, Sandres-Sauné K, Pasquier C, Marchou B, Massip P, Izopet J.

J Acquir Immune Defic Syndr. 2010 Feb;53(2):167-75. doi: 10.1097/QAI.0b013e3181c8413b.

PMID:
19996764
15.

Prevalence study of yaws in the Democratic Republic of Congo using the lot quality assurance sampling method.

Gerstl S, Kiwila G, Dhorda M, Lonlas S, Myatt M, Ilunga BK, Lemasson D, Szumilin E, Guerin PJ, Ferradini L.

PLoS One. 2009 Jul 22;4(7):e6338. doi: 10.1371/journal.pone.0006338.

16.

Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007).

Micol R, Buchy P, Guerrier G, Duong V, Ferradini L, Dousset JP, Guerin PJ, Balkan S, Galimand J, Chanroeun H, Lortholary O, Rouzioux C, Fontanet A, Leruez-Ville M.

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):486-91. doi: 10.1097/QAI.0b013e3181a254c2.

PMID:
19421071
17.

Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries.

Madec Y, Szumilin E, Genevier C, Ferradini L, Balkan S, Pujades M, Fontanet A.

AIDS. 2009 Apr 27;23(7):853-61. doi: 10.1097/QAD.0b013e32832913ee.

PMID:
19287299
18.

No association between human herpesvirus 6 reactivation and cryptococcosis in human immunodeficiency virus-infected patients.

Micol R, Buchy P, Galimand J, Veasna D, Ferradini L, Balkan S, Guerin PJ, Martin PR, Fontanet A, Lortholary O, Rouzioux C, Leruez-Ville M.

J Med Microbiol. 2009 Feb;58(Pt 2):276-7. doi: 10.1099/jmm.0.000992-0. No abstract available.

PMID:
19141751
19.

Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment.

Spire B, Carrieri P, Sopha P, Protopopescu C, Prak N, Quillet C, Ngeth C, Ferradini L, Delfraissy JF, Laureillard D.

Antivir Ther. 2008;13(5):697-703.

20.

Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia.

Ferradini L, Laureillard D, Prak N, Ngeth C, Fernandez M, Pinoges L, Puertas G, Taburet AM, Ly N, Rouzioux C, Balkan S, Quillet C, Delfraissy JF.

AIDS. 2007 Nov 12;21(17):2293-301.

PMID:
18090277
21.

Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients.

Micol R, Lortholary O, Sar B, Laureillard D, Ngeth C, Dousset JP, Chanroeun H, Ferradini L, Guerin PJ, Dromer F, Fontanet A.

J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):555-9.

PMID:
17577124
22.

Severe FOXP3+ and naïve T lymphopenia in a non-IPEX form of autoimmune enteropathy combined with an immunodeficiency.

Zuber J, Viguier M, Lemaitre F, Senée V, Patey N, Elain G, Geissmann F, Fakhouri F, Ferradini L, Julier C, Bandeira A.

Gastroenterology. 2007 May;132(5):1694-704. Epub 2007 Feb 21.

PMID:
17484867
23.

Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test.

Rouet F, Chaix ML, Nerrienet E, Ngo-Giang-Huong N, Plantier JC, Burgard M, Peeters M, Damond F, Ekouevi DK, Msellati P, Ferradini L, Rukobo S, Maréchal V, Schvachsa N, Wakrim L, Rafalimanana C, Rakotoambinina B, Viard JP, Seigneurin JM, Rouzioux C.

J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):380-8.

PMID:
17468666
24.

Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.

Madec Y, Laureillard D, Pinoges L, Fernandez M, Prak N, Ngeth C, Moeung S, Song S, Balkan S, Ferradini L, Quillet C, Fontanet A.

AIDS. 2007 Jan 30;21(3):351-9.

PMID:
17255742
25.

Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda.

Checchi F, Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor WR, Guthmann JP.

Malar J. 2006 Jul 19;5:59.

26.

Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.

Bonnet MM, Pinoges LL, Varaine FF, Oberhauser BB, O'Brien DD, Kebede YY, Hewison CC, Zachariah RR, Ferradini LL.

AIDS. 2006 Jun 12;20(9):1275-9.

PMID:
16816556
27.

Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.

Calmy A, Pinoges L, Szumilin E, Zachariah R, Ford N, Ferradini L; Médecins Sans Frontieres.

AIDS. 2006 May 12;20(8):1163-9.

PMID:
16691068
28.

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, Karungi G, Szumilin E, Balandine S, Fedida G, Carrieri MP, Spire B, Ford N, Tassie JM, Guerin PJ, Brasher C.

Lancet. 2006 Apr 22;367(9519):1335-42.

PMID:
16631912
29.

Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.

Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor W, Checchi F, Guthmann JP.

Lancet. 2005 Apr 23-29;365(9469):1467-73.

PMID:
15850630
30.

Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.

Calmy A, Klement E, Teck R, Berman D, Pécoul B, Ferradini L.

AIDS. 2004 Dec 3;18(18):2353-60. Review. No abstract available.

PMID:
15622311
31.

Detection of low-frequency human antigen-specific CD4(+) T cells using MHC class II multimer bead sorting and immunoscope analysis.

Lemaître F, Viguier M, Cho MS, Fourneau JM, Maillère B, Kourilsky P, Van Endert PM, Ferradini L.

Eur J Immunol. 2004 Oct;34(10):2941-9.

32.

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells.

Viguier M, Lemaître F, Verola O, Cho MS, Gorochov G, Dubertret L, Bachelez H, Kourilsky P, Ferradini L.

J Immunol. 2004 Jul 15;173(2):1444-53.

33.

Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma.

Movassagh M, Spatz A, Davoust J, Lebecque S, Romero P, Pittet M, Rimoldi D, Liénard D, Gugerli O, Ferradini L, Robert C, Avril MF, Zitvogel L, Angevin E.

Cancer Res. 2004 Mar 15;64(6):2192-8.

34.

Phage-displayed libraries of peptide/major histocompatibility complexes.

Dogan I, Dorgham K, Chang HC, Parizot C, Lemaître F, Ferradini L, Reinherz EL, Debré P, Gorochov G.

Eur J Immunol. 2004 Feb;34(2):598-607.

35.

Characterization of antigen-specific repertoire diversity following in vitro restimulation by a recombinant adenovirus expressing human cytomegalovirus pp65.

Hamel Y, Rohrlich P, Baron V, Bonhomme D, Rieux-Laucat F, Necker A, Lemonnier F, Ferradini L, Fischer A, Cavazzana-Calvo M.

Eur J Immunol. 2003 Mar;33(3):760-8.

36.

The repertoires of circulating human CD8(+) central and effector memory T cell subsets are largely distinct.

Baron V, Bouneaud C, Cumano A, Lim A, Arstila TP, Kourilsky P, Ferradini L, Pannetier C.

Immunity. 2003 Feb;18(2):193-204.

37.

Combination of MHC-peptide multimer-based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses.

Lim A, Baron V, Ferradini L, Bonneville M, Kourilsky P, Pannetier C.

J Immunol Methods. 2002 Mar 1;261(1-2):177-94.

PMID:
11861076
38.

[Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring].

Chouaib S, Echchakir H, Angevin E, Guerra N, Kosmatopoulos K, Caignard A, Lim A, Baron V, Ferradini L, Mami-Chouaib F.

Bull Cancer. 2001 Aug;88(8):733-40. Review. French.

39.

A targeted deletion of a region upstream from the Jkappa cluster impairs kappa chain rearrangement in cis in mice and in the 103/bcl2 cell line.

Cocea L, De Smet A, Saghatchian M, Fillatreau S, Ferradini L, Schurmans S, Weill JC, Reynaud CA.

J Exp Med. 1999 May 3;189(9):1443-50.

40.

Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation.

Sbih-Lammali F, Clausse B, Ardila-Osorio H, Guerry R, Talbot M, Havouis S, Ferradini L, Bosq J, Tursz T, Busson P.

Cancer Res. 1999 Feb 15;59(4):924-30.

41.

Negative regulation of Ig gene rearrangement by a 150-bp transcriptional silencer.

Cocea L, Dahan A, Ferradini L, Reynaud CA, Weill JC.

Eur J Immunol. 1998 Sep;28(9):2809-16.

42.

Rearrangement-enhancing element upstream of the mouse immunoglobulin kappa chain J cluster.

Ferradini L, Gu H, De Smet A, Rajewsky K, Reynaud CA, Weill JC.

Science. 1996 Mar 8;271(5254):1416-20.

PMID:
8596914
43.

T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases.

Even J, Lim A, Puisieux I, Ferradini L, Dietrich PY, Toubert A, Hercend T, Triebel F, Pannetier C, Kourilsky P.

Res Immunol. 1995 Feb;146(2):65-80.

PMID:
7481075
44.

Rearrangement of the chicken lambda light chain locus: a silencer/antisilencer regulation.

Ferradini L, Reynaud CA, Lauster R, Weill JC.

Semin Immunol. 1994 Jun;6(3):165-73. Review.

PMID:
7948956
45.

In-situ preferential usage of V alpha 8 T-cell receptor gene segments in a patient with bullous pemphigoid.

Michalaki H, Roman-Roman S, Nicolas JF, Mackensen A, Thivolet J, Triebel F, Hercend T, Ferradini L.

J Autoimmun. 1993 Dec;6(6):827-39.

PMID:
8155259
46.

Limited T-cell receptor diversity in liver-infiltrating lymphocytes from patients with primary biliary cirrhosis.

Diu A, Moebius U, Ferradini L, Genevée C, Roman-Roman S, Claudon M, Delorme D, Meuer S, Hercend T, Praz F.

J Autoimmun. 1993 Oct;6(5):611-9.

PMID:
8240664
47.

The use of anchored polymerase chain reaction for the study of large numbers of human T-cell receptor transcripts.

Ferradini L, Roman-Roman S, Azogui O, Genevée C, Viel S, Hercend T, Triebel F.

Mol Immunol. 1993 Sep;30(13):1143-50.

PMID:
8413318
48.

Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma.

Mackensen A, Ferradini L, Carcelain G, Triebel F, Faure F, Viel S, Hercend T.

Cancer Res. 1993 Aug 1;53(15):3569-73.

49.

Alternatively spliced T cell receptor transcripts expressed in human T lymphocytes.

Roman-Roman S, Ferradini L, Azogui O, Faure F, Hercend T, Triebel F.

Mol Immunol. 1993 Apr;30(5):423-31.

PMID:
8385265
50.

Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.

Ferradini L, Mackensen A, Genevée C, Bosq J, Duvillard P, Avril MF, Hercend T.

J Clin Invest. 1993 Mar;91(3):1183-90.

Supplemental Content

Loading ...
Support Center